RE: Tils Bods are brilliant24 Jul 2021 10:51
Before I start this contributed is a clue for investing in this business rather than deramping it
A contributor on another BB summed it up rather caustically like this -
These lot are absolute jokers;
"Full accounts are here as they didn't want to RNS the important details;
https://ir.tizianalifesciences.com/static-files/eefd92e3-743f-4571-ac64-5a243742975a
Apparently a £468k base salary wasn't enough for Kunwar Shailubhai, so he took an additional £164k bonus...as well as £1.6m in share based payments.
However, the real icing on the case is the £10.2m 'realisation bonus' paid to the chairman...
"In addition to the target bonus mentioned above, Gabriele Cerrone also had a realisation bonus in his contract whereby he was entitled to a realisation bonus amount equal to the Enterprise Value multiplied by 2.5% in the event of a new equity capital raise in excess of £20,000,000. This bonus became payable upon a £44m fundraise carried out on August 5, 2020. The Company equated its market capitalisation on this date to the enterprise value, resulting in a bonus payment of £10,290,230. Gabriele Cerrone agreed to receive this bonus in the form of equity, amounting to 4,763,995 shares. The number of shares to be issued is fixed."
The disclosure of such a bonus arrangement makes the placing last summer look pretty suspect. It's easy to imagine how certain parties could profit from the 650% increase in the share price between March and July, put said profits back into the £52m placing and then make more money back on the other side by shorting the shares. Everyone wins apart from all of the private shareholders drawn in, particularly those unlucky enough to buy above £2.
How is there not a blatant conflict of interest in a chairman being given shares for raising money?!"
Its a bit over done but entertaining & clear enough IMO
Perhaps the company has some substance but it is not the real factor for investing so be wary.
It would be more useful for a SH to be aware of the skill the BoD have shown in ramping the price to suit their self interest (& then letting it drop) and time their entry & exposure with a view to personal benefits that accrue to the BoD.